Rainer Rupprecht
#145,813
Most Influential Person Now
Rainer Rupprecht's AcademicInfluence.com Rankings
Rainer Rupprechtpsychology Degrees
Psychology
#3174
World Rank
#3609
Historical Rank
Clinical Psychology
#284
World Rank
#288
Historical Rank
Download Badge
Psychology
Why Is Rainer Rupprecht Influential?
(Suggest an Edit or Addition)Rainer Rupprecht's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment (2004) (908)
- Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders (2010) (782)
- Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives (1999) (648)
- Effects of antidepressant treatment on neuroactive steroids in major depression. (1998) (440)
- Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties (2003) (423)
- Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. (2007) (392)
- SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression (2004) (340)
- Progesterone receptor-mediated effects of neuroactive steroids (1993) (298)
- A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. (2009) (297)
- Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS (1994) (294)
- Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. (1993) (293)
- Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects (2009) (242)
- The role of allopregnanolone in depression and anxiety (2014) (222)
- Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. (1993) (189)
- Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery (1999) (188)
- The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner (2001) (187)
- Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. (2004) (185)
- Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis (2014) (173)
- Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. (1996) (173)
- Methodological aspects of clinical trials in tinnitus: a proposal for an international standard. (2012) (159)
- Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology (2001) (157)
- Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression (2008) (155)
- The neuropsychopharmacological potential of neuroactive steroids. (1997) (155)
- Progesterone-induced changes in sleep in male subjects. (1997) (153)
- Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. (2006) (152)
- Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. (2000) (149)
- Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism (2006) (144)
- Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression (2002) (142)
- Allopregnanolone affects sleep in a benzodiazepine-like fashion. (1997) (135)
- Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. (1998) (132)
- Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. (2003) (125)
- Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor (2003) (124)
- Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. (1992) (123)
- Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? (2011) (120)
- GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. (2002) (120)
- Substance P serum levels are increased in major depression: preliminary results (2003) (117)
- Serotonin-2A-receptor and -transporter polymorphisms: Lack of association in patients with major depression (2001) (113)
- Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS (1999) (110)
- Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. (1990) (103)
- Identification of a Naturally Occurring Polymorphism in the Promoter Region of the Norepinephrine Transporter and Analysis in Major Depression (2002) (98)
- Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients (2006) (97)
- Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression (2001) (96)
- Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig. (1998) (96)
- Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. (2011) (96)
- Vigabatrin Decreases Cholecystokinin-Tetrapeptide (CCK-4) Induced Panic in Healthy Volunteers (2001) (93)
- Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene (2002) (93)
- Neurosteroids: Molecular mechanisms of action and psychopharmacological significance (1996) (91)
- Haloperidol-induced cell death—mechanism and protection with vitamin E in vitro (1995) (91)
- Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans (1989) (87)
- Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression (2000) (87)
- Antidepressants and Antipsychotic Drugs Colocalize with 5-HT3 Receptors in Raft-Like Domains (2005) (86)
- Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. (2003) (86)
- Auditory cortex is implicated in tinnitus distress: a voxel-based morphometry study (2013) (85)
- Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABAA-receptor modulation (1993) (85)
- Reduced hippocampal volumes associated with the long variant of the tri‐ and diallelic serotonin transporter polymorphism in major depression (2008) (84)
- Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. (2005) (83)
- The Combined Dexamethasone/CRH Test (DEX/CRH Test) and Prediction of Acute Treatment Response in Major Depression (2009) (83)
- The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men (2004) (81)
- The Role of Chemokines in the Pathophysiology of Major Depressive Disorder (2019) (81)
- Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study (2003) (80)
- Feasibility, Safety and Efficacy of Transcutaneous Vagus Nerve Stimulation in Chronic Tinnitus: An Open Pilot Study (2014) (79)
- Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. (1996) (76)
- TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma (2017) (75)
- Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. (2000) (75)
- Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner (2019) (75)
- Po gene expression is modulated by androgens in the sciatic nerve of adult male rats. (1999) (75)
- DNA Methylation Analysis of the Angiotensin Converting Enzyme (ACE) Gene in Major Depression (2012) (74)
- Combined action of the ACE D- and the G-protein β3 T-allele in major depression: a possible link to cardiovascular disease? (2002) (74)
- Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on theraputic outcome in affective disorders (2001) (74)
- Tryptophan metabolism and immunogenetics in major depression: A role for interferon-γ gene (2013) (74)
- Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression (2002) (72)
- Increased ACTH Concentrations Associated with Cholecystokinin Tetrapeptide-Induced Panic Attacks in Patients with Panic Disorder (2000) (70)
- The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy (2005) (69)
- Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa (2012) (68)
- Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. (2008) (68)
- Evidence for an association between a G-protein-β3-gene variant with depression and response to antidepressant treatment (2000) (68)
- Alternative Splicing and Extensive RNA Editing of Human TPH2 Transcripts (2010) (68)
- “I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression (2017) (67)
- Assessment of neuroleptic-like properties of progesterone (1999) (66)
- Hypothalamic–pituitary–adrenocortical system dysregulation and new treatment strategies in depression (2009) (66)
- The complex roles of neurosteroids in depression and anxiety disorders (2008) (65)
- Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side‐Effect Profile (2012) (65)
- Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner (2004) (65)
- Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. (2000) (64)
- Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity (2006) (64)
- Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients (2006) (63)
- Neuroactive steroids and affective disorders (2006) (62)
- α-Thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization (2004) (61)
- Steroid receptor-mediated effects of neuroactive steroids: characterization of structure-activity relationship. (1996) (60)
- A View Behind the Mask of Sanity: Meta-Analysis of Aberrant Brain Activity in Psychopaths (2018) (58)
- Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine (2003) (58)
- Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression (2005) (57)
- Bilateral prefrontal rTMS and theta burst TMS as an add-on treatment for depression: A randomized placebo controlled trial (2015) (56)
- Beta‐1‐adrenergic receptor gene in major depression: Influence on antidepressant treatment response (2003) (55)
- Acute prefrontal rTMS increases striatal dopamine to a similar degree as d-amphetamine (2007) (54)
- The Influence of Subchronic Administration of the Neurosteroid Allopregnanolone on Sleep in the Rat (2001) (54)
- Neuroactive steroids as modulators of depression and anxiety (2005) (54)
- Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. (1989) (53)
- Neurobiology of depression: A neurodevelopmental approach (2018) (52)
- The ACDC Pilot Trial: Targeting the Anterior Cingulate by Double Cone Coil rTMS for the Treatment of Depression (2015) (52)
- Recent progress in pharmacological and non-pharmacological treatment options of major depression. (2006) (52)
- Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders (2012) (51)
- Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine. (2007) (51)
- The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression (2003) (51)
- Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool. (2017) (50)
- Transcranial magnetic stimulation for panic. (2002) (50)
- Enhancing Neurosteroid Synthesis – Relationship to the Pharmacology of Translocator Protein (18 kDa) (TSPO) Ligands and Benzodiazepines (2015) (49)
- TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis (2017) (49)
- Multisite rTMS for the Treatment of Chronic Tinnitus: Stimulation of the Cortical Tinnitus Network—A Pilot Study (2013) (49)
- The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial. (2014) (48)
- Oxidative stress-resistant cells are protected against haloperidol toxicity (1996) (48)
- Predictors for rTMS response in chronic tinnitus (2012) (47)
- To live alone and to be depressed, an alarming combination for the renin–angiotensin–aldosterone-system (RAAS) (2012) (47)
- The neural basis of sex differences in sexual behavior: A quantitative meta-analysis (2016) (47)
- Neuroactive Steroids in Depression and Anxiety Disorders: Clinical Studies (2007) (47)
- Influence of Sleep Deprivation on Neuroactive Steroids in Major Depression (2002) (46)
- Fluoxetine Requires the Endfeet Protein Aquaporin-4 to Enhance Plasticity of Astrocyte Processes (2016) (46)
- Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC) (2017) (45)
- Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression. (1991) (45)
- N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: A putative cellular mechanism for quetiapine as antidepressant (2012) (45)
- Neuroactive steroids as endogenous modulators of anxiety. (2008) (44)
- Functional neuroanatomy of CCK‐4‐induced panic attacks in healthy volunteers (2009) (44)
- The rTPJ’s overarching cognitive function in networks for attention and theory of mind (2016) (44)
- Influence of Age on Effectiveness and Tolerability of Electroconvulsive Therapy (2010) (43)
- Effects of tiagabine on cholecystokinin‐tetrapeptide (CCK‐4)‐induced anxiety in healthy volunteers (2003) (43)
- Tiagabine improves panic and agoraphobia in panic disorder patients. (2001) (42)
- TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis (2018) (42)
- Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain (2011) (42)
- Panic Induction with Cholecystokinin-Tetrapeptide (CCK-4) Increases Plasma Concentrations of the Neuroactive Steroid 3α, 5α Tetrahydrodeoxycorticosterone (3α, 5α-THDOC) in Healthy Volunteers (2005) (42)
- Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study (2018) (41)
- Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease (1990) (41)
- Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases (2013) (41)
- Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells (2019) (40)
- Microglial Pro-Inflammatory and Anti-Inflammatory Phenotypes Are Modulated by Translocator Protein Activation (2019) (40)
- Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers (1998) (40)
- Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study (2007) (39)
- Functional activity and effective connectivity of the posterior medial prefrontal cortex during processing of incongruent mental states (2014) (39)
- Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression (2002) (39)
- The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy (2006) (38)
- Triple-site rTMS for the treatment of chronic tinnitus: a randomized controlled trial (2016) (38)
- Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone (1991) (38)
- Sleep disturbances and depressed mood: A harmful combination associated with increased leptin levels in women with normal weight (2012) (38)
- Plasma Concentrations of Neuroactive Steroids before and after Electroconvulsive Therapy in Major Depression (2005) (37)
- Neurosteroids as Neuromodulators in the Treatment of Anxiety Disorders (2011) (37)
- Impact of Lipid Raft Integrity on 5-HT3 Receptor Function and its Modulation by Antidepressants (2009) (36)
- Triiodothyronine, thyroxine, and tsh response to dexamethasone in depressed patients and normal controls (1989) (36)
- Cortisol, corticotropin, and β-endorphin responses to corticotropin-releasing hormone in patients with atopic eczema (1995) (36)
- The GABAA receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone (1999) (36)
- Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders (2006) (35)
- Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex (2013) (35)
- Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression (2014) (35)
- Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. (2007) (34)
- Combined rTMS treatment targeting the Anterior Cingulate and the Temporal Cortex for the Treatment of Chronic Tinnitus (2015) (34)
- CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells (2019) (33)
- Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep-endocrine activity. (1993) (33)
- Endocrine responses to growth hormone‐releasing hormone, thyrotropin‐releasing hormone and corticotropin‐releasing hormone in depression (1989) (32)
- Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. (2001) (32)
- Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder (2018) (32)
- Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. (2009) (31)
- C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients. (2008) (31)
- Individualized Repetitive Transcranial Magnetic Stimulation Treatment in Chronic Tinnitus? (2017) (30)
- GABAA receptors as targets for novel anxiolytic drugs (2006) (30)
- Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. (1992) (30)
- A neural circuit encoding sexual preference in humans (2016) (30)
- Neuroactive steroids in neuropsychopharmacology. (2001) (30)
- Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials (2017) (29)
- Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression. (2002) (29)
- Anxiolytic effects of vigabatrin in panic disorder. (2001) (29)
- Influence of a functional polymorphism within the angiotensin I-converting enzyme gene on partial sleep deprivation in patients with major depression (2003) (29)
- Connectivity and functional profiling of abnormal brain structures in pedophilia (2015) (29)
- Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds. (2013) (28)
- Insulin‐like growth factor I in depressed patients and controls (1988) (28)
- The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia (2019) (28)
- Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study. (2003) (28)
- Different reactivity of the hypothalamo-pituitary-gonadal-axis in depression and normal controls. (1988) (28)
- Bcl-2 prevents hippocampal cell death induced by the neuroleptic drug haloperidol (1996) (27)
- Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis (1999) (27)
- Effects of Fluoxetine, Indomethacine and Placebo on 3α, 5α Tetrahydroprogesterone (THP) Plasma Levels in Uncomplicated Alcohol Withdrawal (2000) (27)
- Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study (2007) (27)
- Functional antagonistic properties of clozapine at the 5-HT3 receptor. (1996) (26)
- Modulation of Ligand-gated Ion Channels by Antidepressants and Antipsychotics (2007) (26)
- In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in man: relationship to glucocorticoid receptors. (1990) (26)
- Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder. (2009) (26)
- Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy. (2001) (25)
- The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. (2010) (25)
- Neuroactive steroids are not affected by panic induction with 50 microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers. (2004) (25)
- Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls. (2009) (25)
- The dysbindin gene in major depression: An association study (2004) (25)
- The effects of the neuroactive steroid 3α , 5α- THDOC on sleep in the rat (2002) (25)
- The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not in men (2017) (23)
- Assessment of cognitive performance after progesterone administration in healthy male volunteers. (1997) (23)
- Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4). (2007) (23)
- Prolactin response to dexamethasone: A study on normal controls and depressed patients (1987) (22)
- Flunitrazepam Has an Inverse Agonistic Effect on Recombinant α6β2γ2-GABAAReceptors via a Flunitrazepam-binding Site* (1997) (22)
- Impact of Gene-Gender Effects of Adrenergic Polymorphisms on Hypothalamic-Pituitary-Adrenal Axis Activity in Depressed Patients (2008) (22)
- Severe chronic insomnia is not associated with higher body mass index (2015) (22)
- Comparing single-site with multisite rTMS for the treatment of chronic tinnitus – clinical effects and neuroscientific insights: study protocol for a randomized controlled trial (2013) (21)
- Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression. (1989) (21)
- Sleep after intranasal progesterone vs. zolpidem and placebo in postmenopausal women – A randomized, double-blind cross over study (2018) (21)
- The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders. (2015) (21)
- Cognitive behavioral treatment for insomnia is equally effective in insomnia patients with objective short and normal sleep duration. (2020) (21)
- Lithium intoxication after administration of AT1 blockers. (2001) (21)
- Me or you? Neural correlates of moral reasoning in everyday conflict situations in adolescents and adults (2014) (21)
- Elevated glucocorticoid receptor concentrations before and after glucocorticoid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis. (1991) (20)
- Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety? (2013) (20)
- Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. (2000) (20)
- Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO). (2012) (20)
- The gamma amino butyric acid (GABA) receptor alpha‐3 subunit gene polymorphism in unipolar depressive disorder: A genetic association study (2004) (20)
- Allopregnanolone acts as an inhibitory modulator on α1-and α6-containing GABAΑ receptors (1996) (19)
- Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression. (2002) (19)
- Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients. (2001) (18)
- Talking to the synapse: how antidepressants can target glial cells to reshape brain circuits. (2013) (18)
- Analysis of polymorphisms in the olfactory G-protein Golf in major depression (2002) (18)
- Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. (2004) (18)
- Brain stimulation‐induced neuroplasticity underlying therapeutic response in phantom sounds (2018) (18)
- A direct comparison of neuronavigated and non-neuronavigated intermittent theta burst stimulation in the treatment of depression (2021) (17)
- Effects of genetic variants in the TSPO gene on protein structure and stability (2018) (17)
- Benzodiazepines Counteract Rostral Anterior Cingulate Cortex Activation Induced by Cholecystokinin-Tetrapeptide in Humans (2013) (17)
- Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180. (2018) (17)
- Antipsychotic treatment with quetiapine increases the cortical silent period (2014) (17)
- The effect of partial sleep deprivation on computer-based measures of fitness to drive (2016) (16)
- Imbalance in subregional connectivity of the right temporoparietal junction in major depression (2016) (16)
- No influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression (2003) (16)
- Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4. (2008) (16)
- Changes in Subjective-Objective Sleep Discrepancy Following Inpatient Cognitive Behavior Therapy for Insomnia. (2019) (15)
- [Electroconvulsive therapy at the Department of Psychiatry and Psychotherapy, University of Munich. Development during the years 1995-2002]. (2005) (15)
- The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder? (2019) (15)
- Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients (2007) (15)
- Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness. (2014) (15)
- Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery. (1991) (14)
- Structural Brain Changes Following Left Temporal Low-Frequency rTMS in Patients with Subjective Tinnitus (2014) (14)
- False Belief Reasoning in Adults with and without Autistic Spectrum Disorder: Similarities and Differences (2018) (14)
- Pre- and postdexamethasone plasma acth and β-endorphin levels in endogenous and nonendogenous depression (1988) (14)
- Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO) (2022) (14)
- Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: An open-label study (2009) (14)
- Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin Fibroblasts (2020) (13)
- Impact of overnight traffic noise on sleep quality, sleepiness, and vigilant attention in long-haul truck drivers: Results of a pilot study (2015) (13)
- SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat (2020) (13)
- Pharmacological Characterisation of Cortical γ-Aminobutyric Acid Type A (GABAA) Receptors in Two Wistar Rat Lines Selectively Bred for High and Low Anxiety-Related Behaviour (2000) (13)
- Daily high-frequency transcranial random noise stimulation of bilateral temporal cortex in chronic tinnitus – a pilot study (2019) (13)
- Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. (2011) (12)
- Corticotropin-releasing hormone induces depression-like changes of sleep electroencephalogram in healthy women (2016) (12)
- Psychoneuroendocrine research in depression (1989) (12)
- GENDER‐SPECIFIC ASSOCIATION OF VARIANTS IN THE AKR1C1 GENE WITH DIMENSIONAL ANXIETY IN PATIENTS WITH PANIC DISORDER: ADDITIONAL EVIDENCE FOR THE IMPORTANCE OF NEUROSTEROIDS IN ANXIETY? (2014) (12)
- Cognitive Performance Under Electroconvulsive Therapy (ECT) in ECT-Naive Treatment-Resistant Patients With Major Depressive Disorder (2017) (12)
- Comparison of GH responses after human GHRH-44 amide administration and TRH-induced TSH release in depressed patients (1989) (12)
- Marijuana precipitation of panic disorder with agoraphobia (1998) (12)
- Characterization of Glucocorticoid Binding Capacity in Human Mononuclear Lymphocytes: Increase by Metyrapone is Prevented by Dexamethasone Pretreatment (1990) (12)
- Impact of state and trait anxiety on the panic response to CCK-4 (2008) (11)
- Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers. (2005) (11)
- The effects of the neuroactive steroid 3 alpha,5 alpha-THDOC on sleep in the rat. (2002) (11)
- In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression (2005) (11)
- Meta-analysis of brain structural changes after electroconvulsive therapy in depression (2021) (11)
- Glucocorticoids modulate soluble interleukin-2 receptor levels in vivo depending on the state of immune activation and the duration of glucocorticoid exposure. (1993) (10)
- Changes in motor cortex excitability associated with temporal repetitive transcranial magnetic stimulation in tinnitus: hints for cross-modal plasticity? (2014) (10)
- Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT3 Receptors (2009) (10)
- Sexual motivation is reflected by stimulus-dependent motor cortex excitability. (2015) (10)
- Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia. (2014) (10)
- The neural representation of an individualized relational affective space (2018) (10)
- Lack of association of the 5‐HT3A receptor with schizophrenia (2012) (10)
- Multihormonal response to dexamethasone. A study in atopic dermatitis and normal controls. (1991) (10)
- A Pilot Study of Peripheral Muscle Magnetic Stimulation as Add-on Treatment to Repetitive Transcranial Magnetic Stimulation in Chronic Tinnitus (2018) (10)
- Relating experimentally-induced fear to pre-existing phobic fear in the human brain (2017) (10)
- Psychoneuroendocrine research in depression (1989) (10)
- Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio (2020) (9)
- C1q, a small molecule with high impact on brain development: putative role for aging processes and the occurrence of Alzheimer’s disease (2021) (9)
- Macrophage-Derived Chemokine: A Putative Marker of Pharmacological Therapy Response in Major Depression? (2017) (9)
- GDF15 promotes simultaneous astrocyte remodeling and tight junction strengthening at the blood–brain barrier (2020) (9)
- Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders? (2022) (9)
- Impact of TSPO Receptor Polymorphism on [18F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders (2021) (9)
- A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression (2009) (9)
- Effects of glucocorticoids on plasma catecholamines in depression (1989) (9)
- Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3α,5α-tetrahydrodeoxycorticosterone concentrations (2009) (9)
- Attenuation of HPA Axis Hyperactivity and Simultaneous Clinical Deterioration in a Depressed Patient treated with Mirtazapine (2001) (9)
- TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients (2017) (8)
- Flunitrazepam has an inverse agonistic effect on recombinant alpha6beta2gamma2-GABAA receptors via a flunitrazepam-binding site. (1997) (8)
- Topographic mapping of EEG and auditory evoked P300 in neuropsychopharmacology (topographic pharmaco-EEG and pharmaco-AEP 300). (1988) (8)
- Bifrontal high-frequency transcranial random noise stimulation is not effective as an add-on treatment in depression. (2020) (8)
- Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. (2009) (8)
- Neuroactive Steroids in Responders and Nonresponders to Sleep Deprivation (2004) (8)
- Pitfalls in isolating lipid rafts (2007) (8)
- Vigabatrin and Tiagabine Might have Antipanic Properties (2004) (8)
- Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling (2016) (8)
- Glucocortinoid receptors on mononuclear leukocytes in Alzheimer's disease (1990) (8)
- Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids (2021) (8)
- [Considerations in the combination of clozapine and benzodiazepines]. (2004) (8)
- Sleep Endocrine Effects of Megestrol Acetate in Healthy Men (1998) (7)
- Meta-analysis of aberrant brain activity in psychopathy (2017) (7)
- Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment (2021) (7)
- Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression (2022) (7)
- Modulation of ligand-gated ion channels as a novel pharmacological principle. (2011) (7)
- Linking Personality Traits to Individual Differences in Affective Spaces (2020) (6)
- [The German research network for mental disorders]. (2016) (6)
- State- and Trait-Related Alterations of Motor Cortex Excitability in Tinnitus Patients (2014) (6)
- Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity (2010) (6)
- Allopregnanolone acts as an inhibitory modulator on alpha1- and alpha6-containing GABA-A receptors. (1996) (6)
- The influence of 4–week treatment with sertraline on the combined T3/TRH test in depressed patients (2005) (6)
- Treatment of mitral valve prolapse and panic disorder with metoprolol (2000) (6)
- Computerized electroencephalographic topography (CET) during sleep: Topographic hypnograms (1989) (6)
- The Binary Corticosteroid Response: Transcriptional Regulation by Mineralo‐ and Glucocorticoid Receptors (1994) (5)
- Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4. (2009) (5)
- The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy (2010) (5)
- The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls (2005) (5)
- New perspectives in neurosteroid action: open questions for future research (2014) (5)
- A polymorphism in the angiotensin-converting enzyme gene is associated with smoking behavior. (2008) (5)
- The combined T3/TRH test in depressed patients and healthy controls (2005) (5)
- [Significance of GABAA receptors for the pathophysiology and therapy of panic disorders]. (2003) (5)
- Effects of experimentally induced panic attacks on neuroimmunological markers (2009) (5)
- Clinical and biochemical characteristics of early depression in Parkinson’s disease (1989) (5)
- Depressive Kernsymptome (2009) (5)
- Saccadic Eye Velocity after Selective GABAergic Treatment with Tiagabine in Healthy Volunteers (2005) (5)
- Supracategorical fear information revealed by aversively conditioning multiple categories (2020) (4)
- 476. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder (2000) (4)
- Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation in Depression (2003) (4)
- EFFECTS OF CORTICOSTEROIDS AND NEUROSTEROIDS ON SLEEP EEG (1992) (4)
- Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety (2003) (4)
- TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis. (2020) (4)
- [Anticonvulsants in the treatment of anxiety--an alternative treatment option?]. (2007) (4)
- An fMRI study on the comparison of different types of false belief reasoning: False belief-based emotion and behavior attribution (2016) (4)
- [New insights into the pathogenesis and pathophysiology of depression]. (2007) (4)
- Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's disease. (1990) (3)
- Neuroactive steroids as modulators of depression and anxiety (2006) (3)
- Arrythmogenic Right Ventricular Dysplasia (2016) (3)
- Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs (2021) (3)
- Extracellular Signal–Regulated Kinases: A Role for Mood Disorders and the Emotional Component of Pain? (2017) (3)
- Cloned human and murine serotonin3A receptors expressed in human embryonic kidney 293 cells display different single-channel kinetics (2002) (3)
- Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties (2021) (3)
- Electroconvulsive Therapy: Update and New Research (2007) (3)
- Pre- and postdexamethasone cortisol and prolactin levels in sexual dysfunction and normal controls (1988) (3)
- Factors interfering with the 1 mg dexamethasone suppression test in depression. (1987) (3)
- Antidepressants do not modulate estrogen receptor α-mediated gene expression (2001) (3)
- [Non-medicamentous therapy and prevention of Alzheimer disease]. (2001) (3)
- Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxine (2020) (3)
- A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration. (2022) (3)
- Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients (2010) (3)
- In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis (2004) (2)
- Sleepiness and fatigue in multiple sclerosis - same same but different? A systematic review on the Epworth Sleepiness Scale as an assessment tool (2016) (2)
- The neuropsychopharmacological potential of neurosteroids. (1999) (2)
- Happy Gut Bacteria, Happy Brain: The Microbiota-Gut-Brain Axis (2019) (2)
- Topographic mapping of pharmaco-EEG before and after application of phosphatidylserine (1989) (2)
- Using menudriven TEX under MVS (1990) (2)
- Progesterone-induced changes in sleep in healthy male subjects (1997) (2)
- Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response (2007) (2)
- [Gut microbiome and major depressive disorder : The other side of ourselves]. (2016) (2)
- Major depression, cardiovascular risk factors and the Omega-3 index (2011) (2)
- Gonadal steroid and gonadotropin response to dexamethasone: A study in sexual dysfunction and normal controls (2005) (2)
- [Gut microbiota and depression : Pathophysiology of depression: hypothalamic-pituitary-adrenal axis and microbiota-gut-brain axis]. (2020) (2)
- Carbamazepine treatment of adverse psychiatric effects after treatment with the nonsteroidal anti-inflammatory drug piroxicam. (2003) (2)
- [Current aspects of attachment theory and development psychology as well as neurobiological aspects in psychiatric and psychosomatic disorders]. (2003) (2)
- Computer-Assisted Avatar-Based Treatment for Dysfunctional Beliefs in Depressive Inpatients: A Pilot Study (2021) (2)
- Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation (2021) (2)
- Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET. (2020) (2)
- Neuroendocrine dysfunction in depression: comparison of hormonal responses to GHRH, TRH and CRH (1989) (2)
- Antidepressants do not modulate estrogen receptor alpha-mediated gene expression. (2001) (2)
- [Electroconvulsive therapy - indications and practical use for pharmacotherapy resistant depressive disorders]. (2012) (2)
- [The state of psychiatry in Ukraine. Psychiatric hospitals in Kiev and Shitomir]. (2000) (2)
- Antipsychotic drugs antagonise human serotonin type 3 (5-HT3) receptor currents in a noncompetitive manner (2004) (1)
- [Repetitive transcranial magnetic stimulation of the prefrontal cortex--the last resort in the treatment of depression?]. (2004) (1)
- Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptoms (2019) (1)
- Individualized rTMS treatment in chronic tinnitus (2017) (1)
- [New developments in pharmacotherapy of depression]. (2004) (1)
- EPA-1581 - Anxiety-related Neuronal Responses in Phobic Postural Vertigo (2014) (1)
- [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression]. (1988) (1)
- Cortisol and corticotropin (ACTH) responses to corticotropin-releasing hormone (CRH) in Alzheimer's disease (AD) (1989) (1)
- Association of angiotensin I converting enzyme gene I/D polymorphism with therapeutic outcome in depressive disorder (2000) (1)
- Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression (2007) (1)
- 15th Biennial Meeting of the International Pharmaco-EEG Group (IPEG) (2009) (1)
- Albinism with Hemorrhagic Diathesis and Pigmented Reticuloendothelial Cells (2009) (1)
- [Hormonal aspects of erectile dysfunction]. (1989) (1)
- [Diagnosis and treatment of panic disorder]. (2004) (1)
- Plasma concentrations of the neuroactive steroid 3α, 5α tetrahydrodeoxycorticosterone (3α, 5α-THDOC) after panic induction with cholecystokinin-tetrapeptide (CCK–4) in healthy volunteers (2005) (1)
- Response – Vitamin D: the neglected neurosteroid? (2001) (1)
- Selegiline transdermal system in the treatment of depressive disorders (2007) (1)
- [Coincidence of schizophrenia and panic disorder]. (1999) (1)
- Effects of Escitalopram and Relearning on Cortical and Subcortical Grey Matter in Healthy Humans (2021) (1)
- Blunted ACTH but normal β-endorphin response to hCRH in depression (1989) (1)
- [Could depression be the cause?]. (2014) (1)
- [Core symptoms of depression. Effectiveness of antidepressant therapy]. (2009) (1)
- Mapping Research Domain Criteria using a transdiagnostic mini-RDoC assessment in mental disorders: a confirmatory factor analysis (2022) (1)
- Hypothalamic-pituitary-adrenal (HPA) axis activity and response to transcranial magnetic stimulation in responders and nonresponders to sleep deprivation (2000) (1)
- P.1.c.047 A double-blind, placebo-controlled investigation of the anxiolytic effects of XBD173 (AC-5216) and alprazolam using a CCK-4-induced panic challenge (2006) (0)
- Current awareness in human psychopharmacology (2006) (0)
- P.4.f.002 Effects of experimentally induced panic attacks on neuroimmunological markers (2007) (0)
- Hypothalamic-pituitary-somatotropic (HPS) system function in Alzheimer's disease (AD) (1989) (0)
- S.24.04 Neuroactive steroids in affective disorders (2008) (0)
- P310 Brain stimulation-induced neuroplasticity underlying therapeutic response in phantom sounds (2017) (0)
- Glucocorticoid Receptors on Alzheimer's Disease Mononuclear Leukocytes in (1990) (0)
- Influence of reboxetine and mirtazapine on hypothalamic-pituitary-adrenocortical activity in depressed patients (2005) (0)
- Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM (2004) (0)
- Current awareness in human psychopharmacology (2007) (0)
- Neural Correlates of Moral Decision-Making in Neural Correlates of Moral Decision-Making in Psychopaths (2011) (0)
- Correction: comparing single-site with multisite rTMS for the treatment of chronic tinnitus - clinical effects and neuroscientific insights: study protocol for a randomized controlled trial (2014) (0)
- Psychopharmacology- is there still room for progress in these days? (2020) (0)
- Current awareness in human psychopharmacology (2006) (0)
- Electrophysiological effects of phospholipid compounds (1989) (0)
- P.867Effects of etifoxine on general but not stress related expression of the translocator protein 18kDa (TSPO) in healthy subjects (2020) (0)
- Polymorphisms in the angiotensin converting enzyme (ACE) gene are associated with unipolar depression, ACE activity and hypercortisolism (2005) (0)
- Functional neuroanatomy of CCK-4 induced panic attacks: indications for specifically anxiety-related brain activity (2009) (0)
- Translocator Protein (TSPO) Expression in Platelets of Depressed Patients Decreases during Antidepressant Therapy (2016) (0)
- EPA-1654 – Impact on Cortisol and Antidepressant Efficacy of Quetiapine and Escitalopram in Depression (2014) (0)
- Dr. Ströhle and Colleagues Reply (2003) (0)
- Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany (2021) (0)
- Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy. (2022) (0)
- Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options. (2022) (0)
- Structural alterations of amygdala and hippocampus and HPA axis dysregulation in patients with borderline personality disorder (2005) (0)
- PW01-44 - Impact of Glyoxalase-1 Mrna Expression On Cck-4 Induced Anxiety (2010) (0)
- IN VITRO GLUCOCORTICOID‐SENSITIVITY OF LECTIN‐DRIVEN LYMPHOCYTE DNA‐SYNTHESIS AFTER RECOVERY FROM SEVERE MAJOR DEPRESSION. (1992) (0)
- The effects of the neuroactive steroid 3&agr;,5&agr;-THDOC on sleep in the rat (2002) (0)
- Current awareness in human psychopharmacology (1996) (0)
- Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity (2004) (0)
- Association between the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression and polymorphisms in the brain derived neurotropic factor (BDNF) and neurotrophic tyrosine kinase receptor 2 (NTRK2) gene (2005) (0)
- Anticipatory anxiety in phobic postural vertigo patients – functional indicators for anxiety-related disorder (2015) (0)
- Sixth International Congress of Neuroendocrinology. June 19–22, 2006, Pittsburgh, Penn., USA (2007) (0)
- The effects of alprazolam on brain activity in CCK-4-induced panic attacks (2009) (0)
- Subject Index Vol. 58, 2008 (2009) (0)
- THE "YIN AND YANG" IN DEPRESSION: HOW ASTROCYTES AND NEURONS DIFFERENTLY RESPOND TO ANTIDEPRESSANTS TO REMODEL NEURONAL SYNAPTIC CONTACTS (2013) (0)
- [Depressive Disorders in Adolescence: Current State of Studies Concerning the Microbiota-Gut-Brain Axis]. (2023) (0)
- [F-18]GE-180, a novel TSPO-PET tracer for visualization of inflammatory CNS-activity in MS (2017) (0)
- Neurobiologie emotionalyer Dysfunktionen (2018) (0)
- EFFECTS OF MINERALOCORTICOID RECEPTOR LIGANDS ON SLEEP EEG AND NOCTURNAL HORMONE SECRETION ‐ STUDIES WITH DEOXYCORTICOSTERONE AND SPIRONOLACTONE (1992) (0)
- Gonadotropin and gonadosteroid response to dexamethasone in male depressive patients and normal controls (1990) (0)
- Anxiety-related neuronal responses in phobic postural vertigo (2013) (0)
- PW01-103 - Serum Leptin Levels Are Associated With Low Social Ties And Depression (2010) (0)
- Associations between sex, body mass index, and the individual microglial response in Alzheimer’s disease (2021) (0)
- The influence of dexamethasone on growth hormone (GH). Response to GH-releasing hormone in normal men (2005) (0)
- The combined T3/TRH-test in depressed patients and healthy controls (2005) (0)
- Chlamydomonas Swims with Two “ Gears ” in a Eukaryotic Version of Run-and-Tumble Locomotion (2009) (0)
- Author response for "The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder?" (2019) (0)
- Aortic Root to Right Heart Shunts (2009) (0)
- Neuroendocrine dysfunction in early-onset Alzheimer’s disease (1990) (0)
- Andersen disease (2019) (0)
- S.23.03 ACE gene polymorphisms and depression: relation to cardiovascular disease (2007) (0)
- P.2.b.022 A meta-analysis of dose escalation of antidepressant agents in major depressive disorder (2017) (0)
- P.4.a.017 TSPO (18 kDa) – a new pharmacological drug target in anxiety and depression therapy (2014) (0)
- Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humans (2022) (0)
- Polymorphisms in FKBP5, a co-chaperone of the glucocorticoid receptor are associated with response to antidepressant drugs (2004) (0)
- Influence of the angiotensin I converting enzyme gene I/D polymorphism on response to partial sleep deprivation in major depression (2001) (0)
- Current awareness in human psychopharmacology (2004) (0)
- PW01-262 - Influence Of Age On Effectiveness And Tolerability Of Electroconvulsive Therapy (2010) (0)
- Adenomatous Polyposis, Familial (2009) (0)
- Cortisol, growth hormone and prolactin responses to the 5-hydroxytryptamine1A (5-HT1A) receptor ligand ipsapirone (1989) (0)
- The World Journal of Biological Psychiatry – Past, Present and Future (2003) (0)
- Astrocytes and neurons coordinate their responsiveness to antidepressant treatment to modulate synaptic plasticity (2011) (0)
- Impact of selective GABAergic AEDs on CCK-4 induced anxiety and HPA axis activity (2001) (0)
- Room D, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Membrane Cholesterol Affects the Kinetics of 5-HT3 Receptor and GABAA Receptor A-753 (2000) (0)
- Topographic Brain Mapping and Neuroendocrine Parameters in a Patient with Addison’s Disease and a Depressive Syndrome Before and After Treatment with Hydrocortisone (1989) (0)
- Contents Vol. 58, 2008 (2009) (0)
- Impact of lipid raft integrity on GABAA receptor function and its modulation by benzodiazepines (2011) (0)
- Other's Effects on Sleep EEG in the Rat Muscimol and Midazolam Do Not Potentiate Each (2015) (0)
- [Gut and brain]. (2020) (0)
- Postdexamethasone cortisol 7 am/4 pm ratio : a state variable in depression ? (1991) (0)
- 43-4 Psychopharmacological properties of brain-derived cytochrome P450-dependent neuroactive steroids (1997) (0)
- P 414 EEG complexity as an indication for sleep-wake patterns in patients with disorders of consciousness (2017) (0)
- Effects of benzodiazepines on anterior cingulate cortex activity during experimentally induced panic (2014) (0)
- Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease (2023) (0)
- Calculation of the dissociation constant K b of clozapine using the Cheng-Prusoff equation. (2013) (0)
- Individualized Pharmacological Treatment of Depressive Disorders State of the Art and Recent Developments (2014) (0)
- Angiotensin-converting-enzyme gene I/D polymorphism is associated with hyperactivity of the HPA system in depressive patients (2000) (0)
- Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS) (2004) (0)
- Astrocytes or neurons? Cell-type specific responses to antidepressants - from histone modifications to synaptic changes (2017) (0)
- Modulation of ligand-gated ion channels by antidepressants (2004) (0)
- Running title: Sexual motivation in the motor system (2015) (0)
- Improvement of CCK-4 induced panic by selective GABA-transaminase-inhibition with vigabatrin (2000) (0)
- Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors (2009) (0)
- On the role of mitochondrial dysfunction in the molecular pathology of major depressive disorder (2016) (0)
- The influence of mirtazapine on HPA axis activity in depressive patients (2001) (0)
- Aripiprazole has both agonistic and antagonistic effects on the dopaminergic system in endocrinological challenge tests (2007) (0)
- Gender influence on pharmacogenetic prediction of antidepressive efficacy (2004) (0)
- Current awareness in human psychopharmacology (2009) (0)
- P.749 Astrocytes prime a synaptic pruning in the prefrontal cortex upon antidepressant treatment (2020) (0)
- Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment (2022) (0)
- Functional Consequences of the accumulation of psychopharmacological drugs in "lipid rafts" on ligand-gated ion channels (2007) (0)
- Cell-type specific responses to antidepressants - the epigenetic makeup of the glia-neuron interface (2015) (0)
- SLOW WAVE SLEEP INCREASES UNDER PREGNENOLONE IN MAN (1992) (0)
- GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety (2004) (0)
- Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease. (2008) (0)
- S33-01 - Modulation of Ligand Gated Ion Channels by Antidepressants (2010) (0)
- S.15.02 Modulation of GABA-A receptor function for the treatment of anxiety disorders (2014) (0)
- Chapter 4.8 – Neuroactive steroids (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rainer Rupprecht?
Rainer Rupprecht is affiliated with the following schools:
